Unresponsive Wakefulness Syndrome Not Otherwise Explained clinical trials

Explore recruiting unresponsive wakefulness syndrome not otherwise explained clinical trials.

Also recruiting in Europe

Unresponsive Wakefulness Syndrome Not Otherwise Explained trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

AmaNtadine for NeuroenhancEment in acutE patients Study - A prospective pilot proof of concept phase IIb study in intensive and intermediate care unit patients (ANNES)

Germany

Therapeutic exploratory (Phase II) EU CTIS Study details

Unresponsive Wakefulness Syndrome Not Otherwise Explained trials by city

Unresponsive Wakefulness Syndrome Not Otherwise Explained in Toronto Unresponsive Wakefulness Syndrome Not Otherwise Explained in Vancouver Unresponsive Wakefulness Syndrome Not Otherwise Explained in Montreal Unresponsive Wakefulness Syndrome Not Otherwise Explained in Calgary Unresponsive Wakefulness Syndrome Not Otherwise Explained in Edmonton Unresponsive Wakefulness Syndrome Not Otherwise Explained in Ottawa Unresponsive Wakefulness Syndrome Not Otherwise Explained in Winnipeg Unresponsive Wakefulness Syndrome Not Otherwise Explained in Quebec City Unresponsive Wakefulness Syndrome Not Otherwise Explained in Hamilton Unresponsive Wakefulness Syndrome Not Otherwise Explained in Kitchener Unresponsive Wakefulness Syndrome Not Otherwise Explained in London Unresponsive Wakefulness Syndrome Not Otherwise Explained in Halifax Unresponsive Wakefulness Syndrome Not Otherwise Explained in New York Unresponsive Wakefulness Syndrome Not Otherwise Explained in Los Angeles Unresponsive Wakefulness Syndrome Not Otherwise Explained in Chicago Unresponsive Wakefulness Syndrome Not Otherwise Explained in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease